GGrantIndex
Sort

130,381 grants matching hiv

Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa

$1,099,420
Robert H Remien · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2018 · AI

Molecular and Cellular Biology of HIV Encephalopathy

$1,099,199
Francisco A Gonzalez-Scarano · University Of Pennsylvania · P50 · FY2008 · NS

Synthesis of Therapeutic Agents for Treatment of Infectious Diseases

$1,098,964
John Givens · Starks Associates Inc · N01 · FY2016 · AI

Following a U.S. National Cohort of Vulnerable Men to Improve HIV Prevention and Care

$1,098,807
Christian Grov · Graduate School Of Public Health And Health Policy · UH3 · FY2021 · AI

Structure and immunogenicity of novel trimeric HIV-1 Env immunogens

$1,098,437
Xiangpeng Kong · New York University School Of Medicine · R01 · FY2022 · AI

DEFINING ANTI-VIRAL ACT. IN ECHINACEA, HYPERICUM & PRUNELLA SPECIES/MAURY,WENDY

$1,098,209
Diane F Birth · Iowa State University · P50 · FY2008 · AT

Structural Biology Core

$1,098,031
Stephen C Harrison · Duke University · U19 · FY2010 · AI

Training in the Epidemiology and Control of HIV/AIDS in China, SE Asia and India

$1,098,014
Roger Detels · University Of California Los Angeles · D43 · FY2007 · TW

Harvard Medical School Vaccine Clinical Trials Unit

$1,097,943
Raphael Dolin · Beth Israel Deaconess Medical Center · U01 · FY2009 · AI

Rio Grande Valley Cancer Health Disparity Research Center

$1,097,555
Murali Mohan Yallapu · University Of Texas Rio Grande Valley · U54 · FY2025 · MD

Signal Processing And Instrumentation Section

$1,097,447
Thomas J Pohida · Center For Information Technology · ZIA · FY2015 · CT

HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA

$1,097,154
Elizabeth Maleche Obimbo · University Of Nairobi · U62 · FY2006 · PS

Env evolution in humans and RMs

$1,097,115
George M Shaw · University Of Pennsylvania · P01 · FY2020 · AI

Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa

$1,097,066
Blossom A Damania · Univ Of North Carolina Chapel Hill · U54 · FY2023 · CA

Development of Antiviral Therapy of HIV-1 Infection

$1,097,025
Hiroaki Mitsuya · Clinical Sciences · Z01 · FY2007 · CA

Appalachian Tri-State Node

$1,096,827
Dennis C Daley · University Of Pittsburgh At Pittsburgh · U10 · FY2013 · DA

Texas Center for Minority Health, Education, Research and Outreach

$1,096,778
Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · P20 · FY2013 · MD

?Resetting immune homeostasis: a non-invasive approach towards HIV eradication

$1,096,736
Rafick-Pierre Sekaly · Case Western Reserve University · U01 · FY2019 · AI

Mechanisms of Immune Activation and Disease Progression in Animal Models

$1,096,633
Jason Brenchley · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

ULTRAFAST OPTICAL PROCESSES LABORATORY

$1,096,627
Feng Gai · University Of Pennsylvania · P41 · FY2012 · GM

Role of Viral Reservoirs in the Pathogenesis of HIV Disease

$1,096,590
Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

ALCOHOL, HIV, AND THE BRAIN

$1,096,560
Sri International · R01 · FY2003 · AA

Models of SBIRT for Opioid Dependent Patients in the Emergency Department

$1,096,403
Gail D'onofrio · Yale University · R01 · FY2010 · DA

Recombinant Adenovirus Vector Vaccine Studies

$1,096,350
Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

CBA (HIV) PREVENTION SERVICES FOR RACIAL/ETHNIC MINORITY POPULATIONS

$1,096,238
Lina Sheth · Asian And Pacific Islander Wellness Ctr · U65 · FY2008 · PS